Financière de Tubize SA (TUB.BR)

EUR 138.8

(-0.86%)

EBITDA Summary of Financière de Tubize SA

  • Financière de Tubize SA's latest annual EBITDA in 2023 was 184.57 Thousand EUR , up 3.44% from previous year.
  • Financière de Tubize SA's latest quarterly EBITDA in 2024 Q2 was -878.54 Thousand EUR , down 0.0% from previous quarter.
  • Financière de Tubize SA reported an annual EBITDA of - EUR in 2022, down -77.04% from previous year.
  • Financière de Tubize SA reported an annual EBITDA of - EUR in 2021, up 45.62% from previous year.
  • Financière de Tubize SA reported a quarterly EBITDA of -900.66 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
  • Financière de Tubize SA reported a quarterly EBITDA of -993.32 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Financière de Tubize SA (2023 - 2003)

Historical Annual EBITDA of Financière de Tubize SA (2023 - 2003)

Year EBITDA EBITDA Growth
2023 184.57 Thousand EUR 3.44%
2022 - EUR -77.04%
2021 - EUR 45.62%
2020 997 Thousand EUR 23643.22%
2019 -1.09 Million EUR -99.62%
2018 -118 Thousand EUR 6.2%
2017 -151 Thousand EUR 46.65%
2016 -5.82 Million EUR -14.03%
2015 214.11 Million EUR 207.95%
2014 69.52 Million EUR -5.6%
2013 73.65 Million EUR 17720.57%
2012 -13.35 Million EUR -12.97%
2011 -14.68 Million EUR -101.0%
2010 -15.92 Million EUR 9457.36%
2009 -6.31 Million EUR -177.41%
2008 509 Thousand EUR 389.42%
2007 -16.9 Million EUR -99.93%
2006 156.63 Million EUR -48.4%
2005 303.55 Million EUR 129.71%
2004 132.14 Million EUR 2.54%
2003 128.87 Million EUR 0.0%

Peer EBITDA Comparison of Financière de Tubize SA

Name EBITDA EBITDA Difference
ABIONYX Pharma SA -3.29 Million EUR 105.61%
ABIVAX Société Anonyme -133.2 Million EUR 100.139%
Adocia SA -22.73 Million EUR 100.812%
Aelis Farma SA -6.34 Million EUR 102.908%
Biophytis S.A. -13.8 Million EUR 101.337%
Advicenne S.A. -6.24 Million EUR 102.956%
genOway Société anonyme 6.35 Million EUR 97.094%
IntegraGen SA -52.5 Thousand EUR 451.544%
Medesis Pharma S.A. -3.84 Million EUR 104.8%
Neovacs S.A. -8.44 Million EUR 102.184%
NFL Biosciences SA -4.04 Million EUR 104.558%
Plant Advanced Technologies SA 72.53 Thousand EUR -154.475%
Quantum Genomics Société Anonyme -2.87 Million EUR 106.423%
Sensorion SA -22.31 Million EUR 100.827%
Theranexus Société Anonyme -7.38 Million EUR 102.499%
TME Pharma N.V. -5.07 Million EUR 103.639%
Valbiotis SA -6.95 Million EUR 102.654%
TheraVet SA -517.33 Thousand EUR 135.677%
Valerio Therapeutics Société anonyme -18.91 Million EUR 100.976%
argenx SE -199.5 Million EUR 100.093%
BioSenic S.A. -6.79 Million EUR 102.716%
Celyad Oncology SA -7.76 Million EUR 102.378%
DBV Technologies S.A. -79.53 Million EUR 100.232%
Galapagos NV 51.03 Million EUR 99.638%
Genfit S.A. -28.05 Million EUR 100.658%
GeNeuro SA -14.31 Million EUR 101.289%
Hyloris Pharmaceuticals SA -14.98 Million EUR 101.232%
Innate Pharma S.A. -7.57 Million EUR 102.436%
Inventiva S.A. -101.84 Million EUR 100.181%
MaaT Pharma SA -19.74 Million EUR 100.935%
MedinCell S.A. -20.04 Million EUR 100.921%
Nanobiotix S.A. -34.01 Million EUR 100.543%
Onward Medical N.V. -35.23 Million EUR 100.524%
Oryzon Genomics S.A. -4.43 Million EUR 104.163%
OSE Immunotherapeutics SA -23.26 Million EUR 100.793%
Oxurion NV -16.72 Million EUR 101.103%
Pharming Group N.V. 4.98 Million EUR 96.294%
Poxel S.A. -12.17 Million EUR 101.515%
GenSight Biologics S.A. -21.73 Million EUR 100.849%
Transgene SA -27.02 Million EUR 100.683%
UCB SA 1.26 Billion EUR 99.985%
Valneva SE -64.51 Million EUR 100.286%
Vivoryon Therapeutics N.V. -28.35 Million EUR 100.651%